CAS: 1007223-17-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Olokizumab REF: TM-T76753CAS: 1007223-17-7 | 95% - 95% | 240.00 €~1,681.00 € | Wed 16 Apr 25 |
 | Olokizumab REF: 3D-CLA1257CAS: 1007223-17-7 | - - - | To inquire | Mon 28 Apr 25 |
Olokizumab
CAS:1007223-17-7
Revdofilimab (ABBV-368) is a human IgG monoclonal antibody targeting OX 40 with potential anticancer activity.
Purity:
95% - 95%
Color and Shape:
Liquid
Ref: TM-T76753
| 1mg | 240.00 € | ||
| 5mg | 620.00 € | ||
| 10mg | 845.00 € | ||
| 25mg | 1,225.00 € | ||
| 50mg | 1,681.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
Ref: 3D-CLA1257
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025
